Publicaciones en las que colabora con Julián de la Torre Cisneros (16)

2016

  1. Impact of cytomegalovirus infection on severe hepatitis c recurrence in patients undergoing liver transplantation

    Transplantation, Vol. 100, Núm. 3, pp. 593-599

  2. Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients

    Transplant Infectious Disease, Vol. 18, Núm. 6, pp. 819-831

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA/REIPI cohort

    Transplantation, Vol. 92, Núm. 5, pp. 543-549

  4. Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

    Liver Transplantation, Vol. 17, Núm. 8, pp. 896-904

  5. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

    Transplantation, Vol. 92, Núm. 3, pp. 346-350

2010

  1. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

    Transplantation, Vol. 89, Núm. 7, pp. 779-795

2008

  1. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation

    Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882

2007

  1. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: Data from the RESITRA Study Group

    American Journal of Transplantation, Vol. 7, Núm. 4, pp. 964-971

  2. Update on invasive fungal infections: the last two years

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 19-27

2006

  1. A review of critical periods for opportunistic infection in the new transplantation era

    Transplantation, Vol. 82, Núm. 11, pp. 1457-1462

2005

  1. Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus in transplanted patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 7, pp. 424-437

  2. Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (Marzo 2005)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 6, pp. 353-362

  3. Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study

    Clinical Infectious Diseases, Vol. 41, Núm. 1, pp. 52-59

1997

  1. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain

    Transplantation, Vol. 63, Núm. 9, pp. 1278-1286